+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Metastatic Breast Cancer Treatment Market Research Report by Treatment Type (Biologic Targeted Therapy, Breast Surgery, and Chemotherapy), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 225 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4968652
UP TO OFF until Dec 31st 2022
The Global Metastatic Breast Cancer Treatment Market size was estimated at USD 17.27 billion in 2021, USD 19.33 billion in 2022, and is projected to grow at a CAGR 12.10% to reach USD 34.29 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Metastatic Breast Cancer Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Treatment Type, the market was studied across Biologic Targeted Therapy, Breast Surgery, Chemotherapy, Hormone Therapy, and Radiation Therapy.
  • Based on End User, the market was studied across Clinics and Hospitals.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Metastatic Breast Cancer Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Metastatic Breast Cancer Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Metastatic Breast Cancer Treatment Market, including AstraZeneca Plc, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson and Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sun Pharmaceutical Industries Ltd.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Metastatic Breast Cancer Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Metastatic Breast Cancer Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Metastatic Breast Cancer Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Metastatic Breast Cancer Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Metastatic Breast Cancer Treatment Market?
6. What is the market share of the leading vendors in the Global Metastatic Breast Cancer Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Metastatic Breast Cancer Treatment Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Cases of Breast Cancers
5.1.1.2. Rise in Awareness Among People for Metastatic Breast Cancer Treatment
5.1.1.3. Openness to Ionizing and Ultraviolet Radiation
5.1.2. Restraints
5.1.2.1. Side Effect Associated with the Treatment
5.1.3. Opportunities
5.1.3.1. Robust Technological Advancement in the Cancer Treatments
5.1.3.2. Ongoing Research and Development in the Metastatic Breast Cancer Treatment
5.1.4. Challenges
5.1.4.1. Costly Procedures of Metastatic Breast Cancer Treatments
5.2. Cumulative Impact of COVID-19
6. Metastatic Breast Cancer Treatment Market, by Treatment Type
6.1. Introduction
6.2. Biologic Targeted Therapy
6.3. Breast Surgery
6.4. Chemotherapy
6.5. Hormone Therapy
6.6. Radiation Therapy
7. Metastatic Breast Cancer Treatment Market, by End-user
7.1. Introduction
7.2. Clinics
7.3. Hospitals
8. Americas Metastatic Breast Cancer Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Metastatic Breast Cancer Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Metastatic Breast Cancer Treatment Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. Fpnv Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, by Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Astrazeneca plc
12.2. Bayer Ag
12.3. Eli Lilly and Company
12.4. F. Hoffmann-La Roche Ag
12.5. GlaxoSmithKline plc
12.6. Johnson and Johnson
12.7. Merck & Co., Inc.
12.8. Novartis Ag
12.9. Pfizer Inc.
12.10. Sun Pharmaceutical Industries Ltd
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET DYNAMICS
FIGURE 8. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2027
FIGURE 11. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BIOLOGIC TARGETED THERAPY, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BIOLOGIC TARGETED THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BREAST SURGERY, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BREAST SURGERY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HORMONE THERAPY, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY RADIATION THERAPY, 2019-2027 (USD BILLION)
FIGURE 20. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 22. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2027
FIGURE 24. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CLINICS, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HOSPITALS, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 29. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 30. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 32. ARGENTINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 33. BRAZIL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 34. CANADA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 35. MEXICO METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 36. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 37. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 38. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY STATE, 2027
FIGURE 40. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 42. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 44. AUSTRALIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. CHINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. INDIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. INDONESIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. JAPAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. MALAYSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. PHILIPPINES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. SINGAPORE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. SOUTH KOREA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. TAIWAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. THAILAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2027
FIGURE 59. FRANCE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. GERMANY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. ITALY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. NETHERLANDS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. QATAR METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. RUSSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. SAUDI ARABIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. SOUTH AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. SPAIN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. UNITED ARAB EMIRATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. UNITED KINGDOM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 71. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BIOLOGIC TARGETED THERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BIOLOGIC TARGETED THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BIOLOGIC TARGETED THERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BIOLOGIC TARGETED THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BIOLOGIC TARGETED THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BREAST SURGERY, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BREAST SURGERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BREAST SURGERY, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BREAST SURGERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BREAST SURGERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 17. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 19. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 22. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HORMONE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HORMONE THERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 24. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HORMONE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HORMONE THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2019-2027 (USD BILLION)
TABLE 27. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY STATE, 2019-2027 (USD BILLION)
TABLE 29. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 32. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 33. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CLINICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 35. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD BILLION)
TABLE 38. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD BILLION)
TABLE 40. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 43. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 45. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 46. ARGENTINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 47. ARGENTINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 48. ARGENTINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 49. BRAZIL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 50. BRAZIL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 51. BRAZIL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 52. CANADA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 53. CANADA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 54. CANADA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 55. MEXICO METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 56. MEXICO METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 57. MEXICO METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 58. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 59. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 60. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 61. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 62. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 63. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 65. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 66. AUSTRALIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 67. AUSTRALIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 68. AUSTRALIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 69. CHINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 70. CHINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 71. CHINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 72. INDIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 73. INDIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 74. INDIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 75. INDONESIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 76. INDONESIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 77. INDONESIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 78. JAPAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 79. JAPAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 80. JAPAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 81. MALAYSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 82. MALAYSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 83. MALAYSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 84. PHILIPPINES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 85. PHILIPPINES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 86. PHILIPPINES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 87. SINGAPORE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. SINGAPORE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 89. SINGAPORE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 90. SOUTH KOREA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 91. SOUTH KOREA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 92. SOUTH KOREA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 93. TAIWAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. TAIWAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 95. TAIWAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 96. THAILAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. THAILAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 98. THAILAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 103. FRANCE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 104. FRANCE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 105. FRANCE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 106. GERMANY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 107. GERMANY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 108. GERMANY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 109. ITALY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 110. ITALY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 111. ITALY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 112. NETHERLANDS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 113. NETHERLANDS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 114. NETHERLANDS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 115. QATAR METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 116. QATAR METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 117. QATAR METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 118. RUSSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 119. RUSSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 120. RUSSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 121. SAUDI ARABIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 122. SAUDI ARABIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 123. SAUDI ARABIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 124. SOUTH AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 125. SOUTH AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 126. SOUTH AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 127. SPAIN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 128. SPAIN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 129. SPAIN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 130. UNITED ARAB EMIRATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 131. UNITED ARAB EMIRATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 132. UNITED ARAB EMIRATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 133. UNITED KINGDOM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 134. UNITED KINGDOM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2019-2027 (USD BILLION)
TABLE 135. UNITED KINGDOM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 136. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 137. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 138. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 139. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET RANKING
TABLE 140. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
TABLE 141. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET MERGER & ACQUISITION
TABLE 142. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 143. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 144. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET INVESTMENT & FUNDING
TABLE 145. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 146. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • AstraZeneca Plc
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd

Methodology

Loading
LOADING...